<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Accumulating evidence suggests that chemopreventive effects of some dietary <z:chebi fb="0" ids="26195">polyphenols</z:chebi> may in part be mediated by their ability to influence epigenetic mechanisms in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="1" pm="."><plain>Boswellic acids, derived from the plant Boswellia serrata, have long been used for the treatment of various <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory diseases</z:e> due to their potent anti-inflammatory activities </plain></SENT>
<SENT sid="2" pm="."><plain>Recent preclinical studies have also suggested that this compound has anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> potential against various <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>However, the precise molecular mechanisms underlying their anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> effects remain elusive </plain></SENT>
<SENT sid="4" pm="."><plain>Herein, we report that boswellic acids modulate DNA methylation status of several <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) cells </plain></SENT>
<SENT sid="5" pm="."><plain>We treated RKO, SW48 and SW480 <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines with the active principle present in boswellic acids, <z:chebi fb="9" ids="46887">acetyl</z:chebi>-keto-Î²-boswellic acid (AKBA) </plain></SENT>
<SENT sid="6" pm="."><plain>Using genome-wide DNA methylation and gene expression microarray analyses, we discovered that AKBA induced a modest genome-wide demethylation that permitted simultaneous re-activation of the corresponding <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes </plain></SENT>
<SENT sid="7" pm="."><plain>The quantitative methylation-specific PCR and RT-PCR validated the gene demethylation and re-expression in several putative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes including SAMD14 and SMPD3 </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, AKBA inhibited DNMT activity in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="9" pm="."><plain>Taken together, these results lend further support to the growing notion that anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> effect of boswellic acids may in part be due to its ability to demethylate and reactivate methylation-silenced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes </plain></SENT>
<SENT sid="10" pm="."><plain>These results suggest that not only boswellic acid might be a promising epigenetic modulator in the chemoprevention and treatment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, but also provide a rationale for future investigations on the usefulness of such botanicals for epigenetic therapy in other human <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
</text></document>